Inserm

show This article may be expanded with text translated from the corresponding article in French. (February 2020) Click [show] for important translation instructions. View a machine-translated version of the French article. Machine translation like DeepL or Google Translate is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia. Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article. You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary Content in this edit is translated from the existing French Wikipedia article at [[:fr:Institut national de la santé et de la recherche médicale]]; see its history for attribution. You should also add the template {{Translated|fr|Institut national de la santé et de la recherche médicale}} to the talk page. For more guidance, see Wikipedia:Translation.

Institut national de la santé et de la recherche médicale

Abbreviation	Inserm
Formation	1964
Type	Governmental organization
Location	Paris
Region served	France
Official language	French
Director	Claire Giry (interim)
Staff	6,500
Website	inserm.fr/en

The Institut national de la santé et de la recherche médicale (Inserm, French pronunciation: ​[insɛʁm]) is the French National Institute of Health and Medical Research.

History and organisation[]

Inserm was created in 1964 as a successor to the French National Institute of Health.^{[citation needed]}

Inserm is the only public research institution solely focused on human health and medical research in France.^[1] It is a public institution with a scientific and technical vocation under the dual auspices of the Ministry of Health and the Ministry of Research.^{[citation needed]} Similarly to the US National Institutes of Health, Inserm conducts fundamental and translational research projects through 339 research units, run by around 13,000 scientists, including 5,100 permanent research staff members and 5,100 staff members co-affiliated with university hospitals and medicine faculties. Inserm's laboratories and research units are located all over France, mainly in the largest cities. Eighty percent of Inserm research units are embedded in research hospitals of French universities.^{[citation needed]}. In April 2020, Inserm researchers, Dr. Camille Locht and Dr. Jean-Paul Mira, suggested on live television that COVID-19 experimental drugs be tested in Africa, despite the fact that Africa had the fewest cases of the virus in the world. After the comments were widely denounced as racist, Inserm and the two researchers released statements of apology.^[2]

Inserm's CEO is chosen by decree upon a proposal of the Ministers of Health and Research, advised by a review committee.^[3] The CEO since January 2019 is Gilles Bloch, a doctor and researcher specializing in medical imaging.^[4]

Ranking[]

According to the 2019 Scimago Institutions Ranking, Inserm is ranked 2nd best research institution in the health sector (behind the NIH), and 22nd across all sectors.^[5]

Awards[]

Nobel prizes[]

Two Inserm research scientists have been awarded by the Nobel Prize in Physiology or Medicine. In 1980, the French immunologist Jean Dausset received the Nobel prize (along with Baruj Benacerraf and George Davis Snell), for his work on the discovery and characterisation of the genes making the major histocompatibility complex. In 2008, the French virologist Françoise Barré-Sinoussi was awarded, together with her former mentor Luc Montagnier, for the identification of the human immunodeficiency virus.

Grand prix de l'Inserm[]

Each year, Inserm awards three researchers in three major distinct categories. The Grand prix de l'Inserm recognizes major advancements in biology for an active researcher of the institution, the Grand prix d'honneur recognizes a French public institution's researcher whose contributions have had a major impact in science, and the Prix étranger (Foreign Prize) awards a foreign researcher for their particular contributions to biomedical research. In addition the Inserm has internal awards for engineers and young researchers.

Awardees[]

Notes and references[]

External links[]

• Official website (English)

show This article may be expanded with text translated from the corresponding article in French. (October 2016) Click [show] for important translation instructions. View a machine-translated version of the French article. Machine translation like DeepL or Google Translate is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia. Consider adding a topic to this template: there are already 4,171 articles in the main category, and specifying|topic= will aid in categorization. Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article. You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary Content in this edit is translated from the existing French Wikipedia article at [[:fr:Institut national de la santé et de la recherche médicale]]; see its history for attribution. You should also add the template {{Translated|fr|Institut national de la santé et de la recherche médicale}} to the talk page. For more guidance, see Wikipedia:Translation.